[1]司海龙,马仰仰,马一鸣,等.培元抗癌汤联合替加氟对小鼠H22肝癌细胞生长的抑制作用[J].陕西中医,2021,(9):1155-1158.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.001]
 SI Hailong,MA Yangyang,MA Yiming,et al.Inhibitory effect of Peiyuan Kang'ai decoction combined with tegafur on the growth of H22 hepatoma cells in mice[J].,2021,(9):1155-1158.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.001]
点击复制

培元抗癌汤联合替加氟对小鼠H22肝癌细胞生长的抑制作用
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年9期
页码:
1155-1158
栏目:
基础研究
出版日期:
2021-09-05

文章信息/Info

Title:
Inhibitory effect of Peiyuan Kang'ai decoction combined with tegafur on the growth of H22 hepatoma cells in mice
作者:
司海龙马仰仰马一鸣张 洁肖海娟方 瑜王惠玲
(陕西中医药大学,陕西 咸阳 712046)
Author(s):
SI HailongMA YangyangMA YimingZHANG JieXIAO HaijuanFANG YuWANG Huiling
(Shaanxi University of Chinese Medicine,Xianyang 712046,China)
关键词:
H22肝癌细胞 培元抗癌汤 替加氟 肿瘤微环境 癌相关成纤维细胞 趋化因子
Keywords:
H22 hepatoma cells Peiyuan Kang'ai decoction Tegafur Tumor micro-environment Cancer associated fibroblasts Chemokine
分类号:
R 273
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.001
文献标志码:
A
摘要:
目的:观察培元抗癌汤联合替加氟对小鼠H22肝癌细胞生长抑制作用以及对癌相关成纤维细胞(CAFs)调节作用和对细胞因子CXCL1、CXCL2、CXCL8的影响。方法:制备H22肝癌细胞腹水型瘤株悬液,在健康小鼠腋下接种瘤细胞悬液造模,造模成功后随机分为模型组、替加氟组、中西结合组,分别予0.9%的氯化钠溶液、替加氟、培元抗癌汤联合替加氟进行药物干预。观察各组小鼠一般情况,连续用药两周后处死小鼠取瘤组织称重,并计算抑瘤率; Western blot法检测转移瘤中α-SMA、Vimentin、CXCL1、CXCL2、CXCL8蛋白表达水平。结果:干预后,中西结合组较其他两组比较,一般情况较好,小鼠进食、饮水状况良好,体重有所增加,对外部刺激反应敏感,活动无明显异常。替加氟组、中西结合组的瘤体重量明显低于模型组; 中西结合组瘤体重量较替加氟组低,差异有统计学意义(P<0.05)。替加氟组、中西结合组小鼠α-SMA、Vimentin、CXCL1、CXCL2、CXCL8蛋白表达均低于模型组,差异有统计学意义(均P<0.05); 中西结合组的上述指标均低于替加氟组,差异有统计学意义(均P<0.05)。结论:培元抗癌汤联合替加氟能调节肿瘤微环境中CAFs及细胞因子CXCL1、CXCL2、CXCL8,抑制小鼠H22肝癌细胞生长。
Abstract:
Objective:To observe the effects of Peiyuan Kang'ai decoction combined with tegafur on the growth inhibition of mice H22 hepatoma cells,as well as on the regulation of cancer related fibroblasts(CAFs)and the CXCL1,CXCL2,CXCL8 of cytokines.Methods:H22 suspension of ascites type tumor of hepatoma cells was prepared,and the suspension of tumor cells was inoculated under the armpit of healthy mice.After successful modeling,the suspension was randomly divided into model group,tegafluor group,Chinese and western combination group,and the normal saline,tegafluoride,Peyuan Kang'ai decoction and tegafluoride were used for drug intervention respectively.To observe the general condition of each group of mice,the tumor tissue was weighed and the tumor inhibition rate was calculated after two weeks of continuous administration,and the expression level of α-SMA,Vimentin,CXCL1,CXCL2,CXCL8 protein in metastatic tumor was detected by Western blot method.Results:Compared with the other two groups,the Chinese and western combination group was generally better,the mice were in good condition of eating and drinking water,weight increased,sensitive to external stimuli,and no obvious abnormal activity.The weight of tumor in the tegafluoride group and Chinese and western combination group was significantly lower than that in the model group.The weight of tumor in Chinese and western combination group was lower than that in the tegafur group(all P<0.05).The expression of α-SMA,Vimentin,CXCL1,CXCL2,CXCL8 protein in the tegafur group and Chinese and western combination group were lower than those in the model group,difference statistically significant(all P<0.05).The above indexes in the Chinese and western combination group were lower than those in the tegafur group,difference statistically significant(all P<0.05).Conclusion:Peiyuan Kang'ai decoction combined with tegafur can regulate CAFs and cytokines in tumor microenvironment CXCL1,CXCL2,CXCL8,inhibit the growth of H22 hepatoma cells.

参考文献/References:

[1] 丁 宁,宋永波,葛 宁,等.CTCs联合血清肿瘤标记物检测在胃肠道恶性肿瘤术后早期复发的应用价值[J].陕西医学杂志,2017,46(9):1302-1305.
[2] 张向群.肺癌与血清p53抗体关系的研究进展[J].中国急救复苏与灾害医学杂志,2008,3(1):60-63.
[3] 胥孜杭,张 飞,朱杨壮壮,等.肿瘤微环境中不同亚型的髓源抑制性细胞及中医药对其调控作用的研究进展[J].中国实验方剂学杂志,2019,25(14):45-54.
[4] 刘 健,孙增涛,刘 伟,等.益气活血解毒法对肺癌微环境作用探析[J].陕西中医,2018,39(9):1285-1287.
[5] 黄崇标,徐 杰,李增勋.肿瘤相关成纤维细胞在口腔鳞状细胞癌中的作用及其靶向治疗的研究进展[J].中国肺癌杂志,2020,23(4):267-273.
[6] 侯文静.宫颈癌相关成纤维细胞的分离与鉴定[J].中华肿瘤防治杂志,2016,23(3):171-175.
[7] Paccione RJ,Miyazaki H,Pate I,et al.Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference which inhibits growth and motility[J].Molecular Cancer Therapeutics,2008,7(9):2894-2903.
[8] Sugihara H,Ishimoto T,Yasuda T,et al.Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction[J].Med Oncol,2015,32(6):618.
[9] 陈 升.肿瘤相关成纤维细胞分泌趋化因子促进肝癌转移[D].上海:第二军医大学,2016.
[10] Tsuyada A,Chow A,Wu J,et al.CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells[J].Cancer Res,2012,72(11):2768-2779.
[11] Kavandi L,Collier MA,Nguyen H,et al.Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells[J].Journal of Cellular Biochemistry,2012,113(10):3143-3152.
[12] 李仁廷,范秋丽.培元抗癌汤联合FOLFOX4方案化疗治疗中晚期肝癌临床研究[J].辽宁中医杂志,2013,40(1):92-93.
[13] 谢 斌,谢 雄,饶 斌,等.一贯煎对肝癌JAK1/STAT1信号通路及其下游凋亡相关蛋白表达的影响[J].中国实验方剂学杂志,2017,23(18):100-104.
[14] 臧文华,黄显章,唐德才,等.黄芪-莪术联合顺铂诱导肝癌细胞凋亡及其对miR-122a,miR-221,miR-151表达的影响[J].中国实验方剂学杂志,2016,22(17):87-91.
[15] 潘延凤,陶丰宝,王永刚,等.α-平滑肌肌动蛋白在肝癌组织中的表达及其与肝癌侵袭转移的关系[J].中华实验外科杂志,2012,29(3):441-442.
[16] Lederle W,Hartenstein B,Meides A,et al.MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma[J].Carcinogenesis,2010,31(7):1175-1184.
[17] 郑荣寿,左婷婷,曾红梅,等.中国肝癌死亡状况与生存分析[J].中华肿瘤杂志,2015,37(9):697-702.
[18] Ruffini PA.The CXCL8-CXCR1/2 axis as a therapeutic target in breast cancer stem-like cells[J].Frontiers in Oncology,2019,41(9):40.
[19] Nojima H,Konishi T,Freeman CM,et al.Chemokine receptors CXCR1 and CXCR2 differentially regulate exosome release in hepatocytes[J].PLoS One,2016,11(8):165.
[20] 阮善明,孙 钰,张 恺,等.解毒三根汤调节肿瘤相关成纤维细胞抗结肠癌侵袭转移及其对α-SMA、Sirt1、Ki67的影响[J].浙江中医药大学学报,2016,40(3):184-189.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金青年科学基金资助项目(81704066); 陕西省中医药管理局科研课题(2019-ZZ-JC043); 陕西中医药大学益气健脾法防治消化系肿瘤创新团队科研项目(2019-YL06)
更新日期/Last Update: 2021-09-10